Background Image
Table of Contents Table of Contents
Previous Page  8 / 18 Next Page
Information
Show Menu
Previous Page 8 / 18 Next Page
Page Background

RESEARCH ARTICLE

SA JOURNAL OF DIABETES & VASCULAR DISEASE

6

VOLUME 18 NUMBER 1 • JULY 2021

adjust for possible simultaneous confounding of the risk factors, a

multivariate logistic regression was fitted.

The stepwise model selection method was employed to come

up with the final model, which included the following risk factors:

type of hospital, age, parity, MUAC and history of macrosomia for

the WHO criteria. Similarly, a multivariate linear regression was

used to assess the relationship between RBG and the risk factors.

The final selected model included hospital type, BMI and history of

macrosomia.

SAS software version 9.3 (SAS Institute, North Carolina State

University) was used for analysis and all inferences were made at

the 0.05 significance level.

Results

All participants were recruited from urban Blantyre. Fig. 1 shows a

flow chart of participants recruited in the study.

The study population was predominantly young with an average

age of 25.8 years (25th, 50th and 75th percentiles: 22, 25 and 30,

respectively). Six per cent of the women were above 35 years of

age, 66.4% were in the third trimester and 24% were between 24

and 28 weeks’ gestational age. Table 1 compares the demographic

characteristics of women in government and private ANCs.

Women at government-funded facilities were younger, of

higher parity and gravidity, had a lower pregnancy BMI and were

more likely to be HIV positive. Based on MUAC, 9% of the women

were overweight (MUAC 28–31 cm) and 1% were obese (MUAC

≥ 32 cm). There was no difference in the average MUAC between

government and private ANCs. When the BMI in pregnancy was

calculated, half of the women had a normal BMI (average BMI

26 kg/m

2

; 50th percentile 25).

Three per cent of the women had hypertension, but this was

not explored further to determine whether this was pre-eclampsia

or pre-existing hypertension. Eleven per cent of the women had

HIV and of these, 61% had documented records of being on anti-

retroviral therapy.

Tables 2 and 3 show RBG and OGTT results. Only three women

(0.1%) had an RBG level above 11.1 mmol/l. Twelve women (0.5%)

were hypoglycaemic. There was a significant association between

RBG level and attending government ANCs and BMI.

Based on the OGTTs, the overall prevalence of GDM was

1.6% (

n

= 5) and 24.8% (

n

= 65) by WHO and IADPSG criteria,

respectively. The simple kappa coefficient was calculated to

Table 1.

Comparison of demographic characteristics between govern-

ment and private ANCs

Government ANCs Private ANCs

Characteristics

(

n

= 2044)

(

n

= 178)

p

-value

Age (years), mean ± SD 25.8 ± 0.25

29.4 ± 0.6

< 0.0001

Gestational age (weeks),

26.9 ± 0.36

27.6 ± 3.2

0.68

mean ± SD

Parity, mean ± SD

1.2 ± 0.05

0.76 ± 0.13 < 0.0001

Gravidity, mean ± SD

2.5 ± 0.05

2 ± 0.12 < 0.0001

BMI in pregnancy,

26.2 ± 0.3

27.7 ± 0.8

0.0003

mean ± SD

MUAC (cm), mean ± SD 23.7 ± 0.15

23.5 ± 0.6

0.3646

Hypertension,

n

(%)

97 (4.7)

6 (3.3)

0.6574

HIV,

n

(%)

205 (10.0)

15 (8.4)

0.01

DM family history,

n

(%)

15 (0.7)

43 (24.1)

0.1573

Previous miscarriage,

n

(%)

361 (17.6)

41 (23.0)

0.308

ANC, antenatal clinic; BMI, body mass index; MUAC, mid upper-arm

circumference; DM, diabetes mellitus.

Table 2.

Risk factors associated with increasing RBG levels

Parameter

Standard

Variable

estimate

error

t

-value

p

-value

Government ANC –15.50589 4.763

–3.26

0.0013

BMI

1.09278 0.37628

2.90

0.0041

Macrosomia

–22.14294 12.98251 –1.71

0.0898

RBG, random blood glucose; ANC, antenatal clinic; BMI, body mass index.

Table 3.

Comparison of RBG and fasting glucose levels and GDM

prevalence by OGTTs in government and private ANCs

Government

Private

Variable

ANCs

ANCs

Overall

OR (95% CI)

RBG (g/dl),

94.4 ± 20 107 ± 24 94 ± 21

mean ± SD

Fasting glucose

84 ± 16

70 ± 16 81 ± 19

(g/dl), mean ± SD

2-h glucose (g/dl), 84 ± 18

86 ± 53 84 ± 17

mean ± SD

GDM (WHO),

1.4 (0.04–5.5)

0.04 (0–1) 1.6 (0.3–4) 3.5 (0.08–8.1)*

% (95% CI)

GDM (IADPSG), 31.7 (24.6–39.8) 7.8 (3–19.1) 24.8 (19–32) 5.5 (1.9–16)*

% (95% CI)

*GDM prevalence odds ratio for government ANCs vs private ANCs.

RBG, random blood glucose; ANC, antenatal clinic; GDM, gestational

diabetes mellitus; OGTT, oral glucose tolerance test.

Fig. 1.

Recruitment of participants. RBG, random blood glucose; OGTT, oral

glucose tolerance test.

2 350 ANC asked for consent

2 274 consented for RBG

2 222 included in RBG analysis

250 randomly selected for OGTT

193 included in OGTT analysis

76 declined

52 incomplete results

57 absent for OGTT